Post-approval studies (Phase 4)Study completedNCT00796692
What this trial is testing
Nadroparin for the Initial Treatment of Pulmonary Thromboembolism
Who this might be right for
Pulmonary EmbolismThromboembolismVascular Diseases+1 more
Beijing Chao Yang Hospital 274